Literature DB >> 22826318

CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.

John Goulding1, Rebecka Bogue, Vikas Tahiliani, Michael Croft, Shahram Salek-Ardakani.   

Abstract

The precise immune components required for protection against a respiratory Orthopoxvirus infection, such as human smallpox or monkeypox, remain to be fully identified. In this study, we used the virulent Western Reserve strain of vaccinia virus (VACV-WR) to model a primary respiratory Orthopoxvirus infection. Naive mice infected with VACV-WR mounted an early CD8 T cell response directed against dominant and subdominant VACV-WR Ags, followed by a CD4 T cell and Ig response. In contrast to other VACV-WR infection models that highlight the critical requirement for CD4 T cells and Ig, we found that only mice deficient in CD8 T cells presented with severe cachexia, pulmonary inflammation, viral dissemination, and 100% mortality. Depletion of CD8 T cells at specified times throughout infection highlighted that they perform their critical function between days 4 and 6 postinfection and that their protective requirement is critically dictated by initial viral load and virulence. Finally, the ability of adoptively transferred naive CD8 T cells to protect RAG⁻/⁻ mice against a lethal VACV-WR infection demonstrated that they are both necessary and sufficient in protecting against a primary VACV-WR infection of the respiratory tract.

Entities:  

Mesh:

Year:  2012        PMID: 22826318      PMCID: PMC3496758          DOI: 10.4049/jimmunol.1200799

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Respiratory infection of mice with vaccinia virus.

Authors:  G S Turner
Journal:  J Gen Virol       Date:  1967-07       Impact factor: 3.891

2.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Authors:  M K Spriggs; B H Koller; T Sato; P J Morrissey; W C Fanslow; O Smithies; R F Voice; M B Widmer; C R Maliszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Authors:  Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

Review 4.  Recombination centres and the orchestration of V(D)J recombination.

Authors:  David G Schatz; Yanhong Ji
Journal:  Nat Rev Immunol       Date:  2011-03-11       Impact factor: 53.106

Review 5.  Mouse models for studying orthopoxvirus respiratory infections.

Authors:  Jill Schriewer; R Mark L Buller; Gelita Owens
Journal:  Methods Mol Biol       Date:  2004

6.  The smallpox vaccine induces an early neutralizing IgM response.

Authors:  Juan E Moyron-Quiroz; Megan M McCausland; Robin Kageyama; Alessandro Sette; Shane Crotty
Journal:  Vaccine       Date:  2009-10-12       Impact factor: 3.641

7.  OX40 drives protective vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Magdalini Moutaftsi; Shane Crotty; Alessandro Sette; Michael Croft
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  Vaccinia virus zoonotic infection, São Paulo State, Brazil.

Authors:  Jane Megid; Iara A Borges; Jonatas S Abrahão; Giliane S Trindade; Camila M Appolinário; Márcio G Ribeiro; Susan D Allendorf; João Marcelo A P Antunes; André T Silva-Fernandes; Erna G Kroon
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

9.  Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Authors:  Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  25 in total

1.  Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production.

Authors:  Arundhati Ghosh; Lulu Shao; Padmavathi Sampath; Baoyu Zhao; Nidhi V Patel; Jianzhong Zhu; Bharat Behl; Robert A Parise; Jan H Beumer; Roderick J O'Sullivan; Neal A DeLuca; Stephen H Thorne; Vijay A K Rathinam; Pingwei Li; Saumendra N Sarkar
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

2.  Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Authors:  Pavlo Gilchuk; Charles T Spencer; Stephanie B Conant; Timothy Hill; Jennifer J Gray; Xinnan Niu; Mu Zheng; John J Erickson; Kelli L Boyd; K Jill McAfee; Carla Oseroff; Sine R Hadrup; Jack R Bennink; William Hildebrand; Kathryn M Edwards; James E Crowe; John V Williams; Søren Buus; Alessandro Sette; Ton N M Schumacher; Andrew J Link; Sebastian Joyce
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

3.  Inflammatory monocytes contribute to the persistence of CXCR3hi CX3CR1lo circulating and lung-resident memory CD8+ T cells following respiratory virus infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Jessica Stanfield; Georges Abboud; Shahram Salek-Ardakani
Journal:  Immunol Cell Biol       Date:  2018-01-30       Impact factor: 5.126

4.  The TNF Superfamily Molecule LIGHT Promotes the Generation of Circulating and Lung-Resident Memory CD8 T Cells following an Acute Respiratory Virus Infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Tarun E Hutchinson; Farhad Dastmalchi; Jessica Stanfield; Georges Abboud; Paul G Thomas; Carl F Ware; Jianxun Song; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

5.  Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

Authors:  Georges Abboud; Vikas Tahiliani; Pritesh Desai; Kyle Varkoly; John Driver; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

6.  Batf3-Dependent Dendritic Cells Promote Optimal CD8 T Cell Responses against Respiratory Poxvirus Infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Georges Abboud; Jessica Stanfield; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

7.  Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.

Authors:  I V Larsen; H Clausius; A W Kolb; C R Brandt
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

8.  Lack of B Lymphocytes Enhances CD8 T Cell-Mediated Resistance against Respiratory Viral Infection but Compromises Memory Cell Formation.

Authors:  Pritesh Desai; Jessica Stanfield; Vikas Tahiliani; Georges Abboud; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

9.  Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein.

Authors:  Siti Khadijah Kasani; Huei-Yin Cheng; Kun-Hai Yeh; Shu-Jung Chang; Paul Wei-Che Hsu; Shu-Yun Tung; Chung-Tiang Liang; Wen Chang
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

10.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.